Press Releases

Unraveling the Genomic Mysteries with CD Genomics’ RIP-Seq Services

Driving Genomic Research Forward with Advanced CRISPR Sequencing by CD Genomics

Unraveling the Genomic Mysteries with CD Genomics’ RIP-Seq Services

Pioneering Human Whole Genome PacBio SMRT Sequencing with CD Genomics

Principal IRB Becomes Univo IRB With Support From QHP Capital

Univo IRB was announced as the new company name for Principal IRB.

Driving Genomic Research Forward with Advanced CRISPR Sequencing by CD Genomics

PathAI Launches New Pathologist-Centric Features on AISight to Enable Efficient Case Review through Intelligent Case Prioritization and Real-Time Multi-Institutional Collaboration

PathAI, Inc., a leading AI-powered precision pathology company, today announced the availability of two new features on the AISight digital pathology image management system – an Intelligent Caselist and AISight Live.

Creative Enzymes Rolls out Customized Solutions in Enzyme, Probiotic and Extract Blends

UNIVERSITY OF EDINBURGH ACKNOWLEDGES PELAGO PATENT AND USE OF CETSA® PROCESS

Pelago Biosciences has announced that the University of Edinburgh has acknowledged its Cellular Thermal Shift Assay (CETSA®) patent and use thereof in selected works in drug discovery research.

Creative Enzymes Proudly Unveils Its Cutting-Edge Product, Recombinant Human Hyaluronidase PH20

Elligo Health Research Expands EU and U.K. Clinical Trial Support With WHYZE Health

Elligo Health Research announces a new collaboration with Ireland-based WHYZE Health.

Creative Proteomics Unveils Comprehensive Exosome Lipidomics Services

Creative Proteomics Enhances Research Capabilities with Urine Untargeted Metabolomics

Intego Clinical Scientists Accepted to Present on Generative AI and Statistical Programming Challenges in the Pharmaceutical Industry at PHUSE US Connect 2024

Intego Clinical has been accepted to provide three presentations and papers at this year’s PHUSE US Connect – the clinical data science conference.

Creative Proteomics Expands Its Epigenetics Portfolio with Advanced Histone PTMs Analysis Service

Alfa Chemistry Expands Selection of Click Chemistry Reagents: DBCO, BCN, and Tetrazines Included

Rare Disease Day: Emmes Endpoints Solutions Submits Duchenne Video Assessment Qualification Plan to FDA

Cresset® Announces Global Collaboration with Enamine on New Virtual Screening Drug Discovery Technology

Drug discovery specialists Cresset have signed an international collaboration agreement with top global chemical building block providers Enamine to develop new drug discovery technology that can help identify viable drug candidates and unlock future treatment options

Huateng Pharma Introduces Semaglutide Side Chain

Huateng Pharma, a leading provider of high-quality pharmaceutical intermediates, is proud to unveil its latest breakthrough product: Semaglutide Side Chain. This innovative addition to Huateng Pharma's portfolio represents a significant milestone in pharmaceutical innovation, offering a range of compounds including AEEA-AEEA (CAS NO.: 1143516-05-5), SNAC (CAS NO.: 203787-91-1), tBuO-Ste-Glu(AEEA-AEEA)-OtBu (CAS NO.:1118767-16-0), and Fmoc-L-Lys[Oct-(otBu)-Glu-(otBu)-AEEA-AEEA]-OH (CAS NO.: 1662688-20-1).

AES Clean Technology appoints new Vice President of Engineering

Montgomeryville, Pennsylvania, February 20th, 2024: AES Clean Technology, a leading provider of high-performance modular cleanroom facilities, has appointed Chris Barbieri as Vice President of Engineering. With over 20 years of experience in the life science industry and deep expertise in engineering and project delivery, Chris will oversee all aspects of engineering operations, including product development, innovation, and technological advancement initiatives that are aligned with AES’ strategic vision. In addition, he will focus on streamlining the team’s processes, driving consistency, and fostering a culture of technical excellence and innovation.